- Home
- NCNA vs DUO Comparison
NCNA vs DUO Comparison
Compare NCNA & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- DUO
- Stock Information
- Founded
- NCNA 1997
- DUO 2011
- Country
- NCNA United Kingdom
- DUO China
- Employees
- NCNA N/A
- DUO N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- DUO Real Estate
- Sector
- NCNA Health Care
- DUO Finance
- Exchange
- NCNA Nasdaq
- DUO Nasdaq
- Market Cap
- NCNA 6.6M
- DUO 6.1M
- IPO Year
- NCNA 2017
- DUO 2019
- Fundamental
- Price
- NCNA $3.86
- DUO $3.38
- Analyst Decision
- NCNA
- DUO
- Analyst Count
- NCNA 0
- DUO 0
- Target Price
- NCNA N/A
- DUO N/A
- AVG Volume (30 Days)
- NCNA 338.4K
- DUO 6.1M
- Earning Date
- NCNA 08-20-2025
- DUO 08-29-2025
- Dividend Yield
- NCNA N/A
- DUO N/A
- EPS Growth
- NCNA N/A
- DUO N/A
- EPS
- NCNA N/A
- DUO N/A
- Revenue
- NCNA N/A
- DUO $56,189,313.00
- Revenue This Year
- NCNA N/A
- DUO N/A
- Revenue Next Year
- NCNA N/A
- DUO N/A
- P/E Ratio
- NCNA N/A
- DUO N/A
- Revenue Growth
- NCNA N/A
- DUO 48.30
- 52 Week Low
- NCNA $2.78
- DUO $1.24
- 52 Week High
- NCNA $1,650.00
- DUO $74.72
- Technical
- Relative Strength Index (RSI)
- NCNA 41.45
- DUO 58.64
- Support Level
- NCNA $2.82
- DUO $3.15
- Resistance Level
- NCNA $3.60
- DUO $5.34
- Average True Range (ATR)
- NCNA 0.24
- DUO 0.80
- MACD
- NCNA 0.43
- DUO 0.17
- Stochastic Oscillator
- NCNA 74.48
- DUO 50.00
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.